| 摘要 |
A halogenated salicylanilide (other than a brominated salicylanilide), or a pharmaceutically acceptable derivative thereof, for use in the treatment of a propionibacterial condition and/or of acne. The salicylanilide may in particular be a chlorinated salicylanilide such as niclosamide. Other preferred halogenated salicylanilides include closantel, rafoxanide, oxyclozanide and mixtures thereof. Other conditions associated with propionibacteria treatable using the invention include endophthalmitis, wounds, burns, ulcers and body odour. The formulation may be for topical or oral administration. |
